Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy. Results of the EUROCONDOR Clinical Trial

Diabetes - United States
doi 10.2337/db18-0682
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Metanx and Early Stages of Diabetic Retinopathy

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2015English

Effects of P38 MAPK Inhibition on Early Stages of Diabetic Retinopathy and Sensory Nerve Function

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2010English

Green Tea Is Neuroprotective in Diabetic Retinopathy

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2013English

Neuroprotective Effects of C3 Exoenzyme in Excitotoxic Retinopathy

Experimental Eye Research
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2014English

Clinical Features of Diabetic Retinopathy in Pregnancy

Vestnik Oftalmologii
MedicineOphthalmology
2019English

The Effects of Pleiotrophin in Proliferative Diabetic Retinopathy

PLoS ONE
Multidisciplinary
2015English

Neuroprotective Effects of PPARα in Retinopathy of Type 1 Diabetes

PLoS ONE
Multidisciplinary
2019English

Controlled Trial of Methandienone in Treatment of Diabetic Retinopathy.

BMJ
1967English

The RAGE Axis in Early Diabetic Retinopathy

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy